[Qualitative and quantitiative differences in the plasma lipoproteins of obese, hyperlipidemic or normolipidemic men and women]. 1996

V Fernández, and G Campos, and E Rincón, and H Valbuena, and E Ryder, and M E Gomez, and X Raleigh
Instituto de Investigaciones Clínicas, Universidad del Zulia, Maracaibo, Venezuela.

The aim of this study was to evaluate the alterations of the lipoprotein composition and their relation with the insulin-resistance and/or hyperinsulinemia in non diabetic obese patients. Twenty-two no obese(13 women and 9 men) and 30 obese patients (BMI > 30) were studied, who were divided into two groups according to the total lipid levels. The first group was formed by 18 obese patients (10 women and 8 men) with normal serum cholesterol (Chol) concentration < 200 mg/dL and triglycerides (TG) < 150mg/dL (NO), while the second group were formed by 12 obese patients (3 women and 9 men) with elevated Chol level > 200mg/dL and/or TG > 150 mg/dL (HO). A clinical and anthropometric examination was performed to each patient, as well as a glucose tolerance test, including serum glucose and insulin determinations. Likewise, the plasma lipoproteins (VLDL, LDL, HDL2 and HDL3) were isolated by ultracentrifugation and their cholesterol and triglycerides content were determined by enzymatic methods. In this report, we demonstrate the existence of compensatory basal hyperinsulinemia in men and women on both obese patients populations as well as alterations in the lipoprotein composition, mostly a TG overload even on NO. On the other hand, the presence of lipids and lipoproteins modification were obvious in those patients with abdominal obesity, on whom the hyperinsulinemia was more evident, which could be related with the high risk of cardiovascular disease in this kind of patients.

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol

Related Publications

V Fernández, and G Campos, and E Rincón, and H Valbuena, and E Ryder, and M E Gomez, and X Raleigh
April 1975, Metabolism: clinical and experimental,
V Fernández, and G Campos, and E Rincón, and H Valbuena, and E Ryder, and M E Gomez, and X Raleigh
January 1996, Arteriosclerosis, thrombosis, and vascular biology,
V Fernández, and G Campos, and E Rincón, and H Valbuena, and E Ryder, and M E Gomez, and X Raleigh
January 1989, Arteriosclerosis (Dallas, Tex.),
V Fernández, and G Campos, and E Rincón, and H Valbuena, and E Ryder, and M E Gomez, and X Raleigh
January 1977, Nutrition and metabolism,
V Fernández, and G Campos, and E Rincón, and H Valbuena, and E Ryder, and M E Gomez, and X Raleigh
May 1975, Clinica chimica acta; international journal of clinical chemistry,
V Fernández, and G Campos, and E Rincón, and H Valbuena, and E Ryder, and M E Gomez, and X Raleigh
October 2005, Drug development and industrial pharmacy,
V Fernández, and G Campos, and E Rincón, and H Valbuena, and E Ryder, and M E Gomez, and X Raleigh
June 1990, The American journal of clinical nutrition,
V Fernández, and G Campos, and E Rincón, and H Valbuena, and E Ryder, and M E Gomez, and X Raleigh
February 1991, Lipids,
V Fernández, and G Campos, and E Rincón, and H Valbuena, and E Ryder, and M E Gomez, and X Raleigh
January 1995, Psychosomatic medicine,
V Fernández, and G Campos, and E Rincón, and H Valbuena, and E Ryder, and M E Gomez, and X Raleigh
May 1992, Kidney international,
Copied contents to your clipboard!